BP-CC-001

N/A

Report date: 2025/07/10 16:05:49

Base Information

Drug NameBP-CC-001

Drug Alias NameBP CC 001BP-CC-001

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Umbilical cord-derived

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsCartilage Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesBIONCaRT GmbH

China Registration ClassN/A

Develop Information

Active CompaniesBIONCaRT GmbH

Inactive CompaniesN/A

Active IndicationsCartilage Diseases

Inactive IndicationsN/A

Other Information

ATC CodeN/A